These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32361642)

  • 1. Factors associated with appropriate and low-value PSA testing.
    Oswald N; Lin T; Haaland B; Flynn M; Kawamoto K; Cooney KA; Lowrance W; Hanson HA; O'Neil B
    Cancer Epidemiol; 2020 Jun; 66():101724. PubMed ID: 32361642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing and referral patterns in the years surrounding the US Preventive Services Task Force recommendation against prostate-specific antigen screening.
    Hutchinson R; Akhtar A; Haridas J; Bhat D; Roehrborn C; Lotan Y
    Cancer; 2016 Dec; 122(24):3785-3793. PubMed ID: 27658175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining low-value PSA testing in a large retrospective cohort: Finding common ground between discordant guidelines.
    O'Neil B; Martin C; Kapron A; Flynn M; Kawamoto K; Cooney KA
    Cancer Epidemiol; 2018 Oct; 56():112-117. PubMed ID: 30130683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision fatigue in low-value prostate cancer screening.
    Hunt TC; Ambrose JP; Haaland B; Kawamoto K; Dechet CB; Lowrance WT; Hanson HA; O'Neil BB
    Cancer; 2021 Sep; 127(18):3343-3353. PubMed ID: 34043813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study.
    Zanwar P; Lin YL; Kuo YF; Goodwin JS
    BMC Health Serv Res; 2016 Jan; 16():17. PubMed ID: 26772175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen testing among the elderly in community-based family medicine practices.
    Hudson SV; Ohman-Strickland P; Ferrante JM; Lu-Yao G; Orzano AJ; Crabtree BF
    J Am Board Fam Med; 2009; 22(3):257-65. PubMed ID: 19429731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
    Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
    J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.
    Li J; Zhao G; Hall IJ
    Am J Prev Med; 2015 Aug; 49(2):259-63. PubMed ID: 25997905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS; Goel V; Williams JI; Iscoe NA
    CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar perspectives on prostate cancer screening value and new guidelines across patient demographic and PSA level subgroups: A qualitative study.
    Partin MR; Lillie SE; White KM; Wilt TJ; Chrouser KL; Taylor BC; Burgess DJ
    Health Expect; 2017 Aug; 20(4):779-787. PubMed ID: 27807905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Have Patients Been Hearing From Providers Since the 2012 USPSTF Recommendation Against Routine Prostate Cancer Screening?
    Haider MR; Qureshi ZP; Horner R; Friedman DB; Bennett C
    Clin Genitourin Cancer; 2017 Dec; 15(6):e977-e985. PubMed ID: 28625690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal and Racial Trends in Prostate-specific Antigen Screening for U.S. Men With a Family History of Prostate Cancer.
    Dalela D; Malchow T; Butaney M; Majdalany S; Corsi NJ; Rakic I; Sood A; Rogers C; Abdollah F
    Urol Pract; 2023 Sep; 10(5):484-492. PubMed ID: 37347799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Value Prostate Cancer Screening Among Older Men Within the Veterans Health Administration.
    Radomski TR; Huang Y; Park SY; Sileanu FE; Thorpe CT; Thorpe JM; Fine MJ; Gellad WF
    J Am Geriatr Soc; 2019 Sep; 67(9):1922-1927. PubMed ID: 31276198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for prostate cancer: are digital rectal examinations being performed?
    Federman DG; Pitkin P; Carbone V; Concato J; Kravetz JD
    Hosp Pract (1995); 2014 Apr; 42(2):103-7. PubMed ID: 24769789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys.
    Li J; Ding H; Richards TB; Martin I; Kobrin S; Marcus PM
    J Am Board Fam Med; 2018; 31(4):658-662. PubMed ID: 29986994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Community Jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening--a qualitative analysis.
    Rychetnik L; Doust J; Thomas R; Gardiner R; Mackenzie G; Glasziou P
    BMJ Open; 2014 Apr; 4(4):e004682. PubMed ID: 24785399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Value Prostate Cancer Screening Among Young Men With Private Insurance.
    Lange SM; Vehawn J; Choudry MM; Ambrose JP; Cluff CM; Haaland BA; Paudel N; Chipman J; Hanson HA; O'Neil BB
    Urol Pract; 2024 Jan; 11(1):110-115. PubMed ID: 37747942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of prostate-specific antigen testing in a large multiethnic cohort.
    Haque R; Van Den Eeden SK; Jacobsen SJ; Caan B; Avila CC; Slezak J; Sternfeld B; Loo RK; Quinn VP
    Am J Manag Care; 2009 Nov; 15(11):793-9. PubMed ID: 19895183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.